Is SCAL or RYLD a better dividend investment in 2026?

SCAL currently yields 1000000.00% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: SCAL offers higher current income.

What is the dividend yield difference between SCAL and RYLD?

SCAL has a forward dividend yield of 1000000.00% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 999987.86 percentage points.

Home › Compare › SCAL vs RYLD

SCAL vs RYLD: Dividend Comparison 2026

SCAL yields 1000000.00% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SCAL wins by $4.7683925249533696e+36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SCAL

● Live price

1000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.7683925249533696e+36M

Annual income

$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00

Full SCAL calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — SCAL vs RYLD

📍 SCAL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SCAL	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SCAL + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SCAL pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCAL

Annual income on $10K today (after 15% tax)

$85,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, SCAL beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCAL + RYLD for your $10,000?

SCAL: 50%RYLD: 50%

100% RYLD50/50100% SCAL

Portfolio after 10yr

$2.3841962624766848e+36M

Annual income

$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.98%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCAL buys

RYLD buys

No recent congressional trades found for SCAL or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSCALRYLD

Forward yield	1000000.00% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.7683925249533696e+36M	$44.5K ✓
Annual income after 10y	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓	$2,587.35
Total dividends collected	$4.7683311610149396e+36M	$18.8K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SCAL vs RYLD ($10,000, DRIP)

Year	SCAL Portfolio	SCAL Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$11,914	$1,213.65	+$100.00M → SCAL
2	$934,786,450,701	$934,679,439,252.34	$14,099	$1,351.30	+$934786.44M → SCAL
3	$8,165,787,108,578,292	$8,164,786,887,076,042.00	$16,580	$1,494.55	+$8165787108.56M → SCAL
4	$66,665,884,190,957,650,000	$66,657,146,798,751,470,000.00	$19,384	$1,642.61	+$66665884190957.63M → SCAL
5	$508,662,171,058,048,100,000,000	$508,590,838,561,963,700,000,000.00	$22,535	$1,794.70	+$508662171058048128.00M → SCAL
6	$3,627,235,248,428,489,700,000,000,000	$3,626,690,979,905,457,600,000,000,000.00	$26,063	$1,950.00	+$3.62723524842849e+21M → SCAL
7	$24,173,681,159,150,610,000,000,000,000,000	$24,169,800,017,434,790,000,000,000,000,000.00	$29,995	$2,107.69	+$2.417368115915061e+25M → SCAL
8	$150,567,402,861,454,640,000,000,000,000,000,000	$150,541,537,022,614,370,000,000,000,000,000,000.00	$34,361	$2,266.99	+$1.5056740286145463e+29M → SCAL
9	$876,477,100,281,847,600,000,000,000,000,000,000,000	$876,315,993,160,785,800,000,000,000,000,000,000,000.00	$39,194	$2,427.12	+$8.764771002818475e+32M → SCAL
10	$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00	$44,525	$2,587.35	+$4.7683925249533696e+36M → SCAL

SCAL vs RYLD: Complete Analysis 2026

SCAL — Stock

Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of stem cells. It specializes in the collection and cryogenic preservation of the hematopoietic stem cells from the umbilical cord blood; and the Miracle Mesenchymal stem cells from the Wharton's jelly inside the umbilical cord of a newborn child. The company's technology enables birthing professionals with a stem cell preservation program to serve their maternity patients in the United States. Stem Cell Authority, Ltd. is based in Fairlawn, Ohio.

Full SCAL Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this SCAL vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCAL vs SCHD SCAL vs JEPI SCAL vs O SCAL vs KO SCAL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.